Par Pharmaceutical Companies, Inc. : Par Pharmaceutical Companies to Report Second Quarter 2012 Results on August 2, 2012
07/09/2012| 09:05am US/Eastern
WOODCLIFF LAKE, N.J., July 9, 2012 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Thursday, August 2, 2012 at 9:00 AM EDT to review results for the second quarter 2012. The Company will release its financial results on August 2, 2012 before the market opens.
Access to the live webcast can be made via the Company's website at www.parpharm.com.
A replay of the conference call will be available for two weeks approximately one hour after the call.
Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.
SOURCE Par Pharmaceutical Companies, Inc.